) and the appearance of the dark blue peak (Tri-0SA) after Sialidase S digestion for the first fraction; (C) the disappearance of the red peak (Tri-2SA) and the appearance of the purple peak (Tri-SA) after Sialidase digestion for the second fraction; and (D) no change of the red peak (Tri-2SA) after Sialidase S digestion for the third fraction.
Figures B-D contain SRM traces for all three possible glycans resulting from this treatment, i.e., the Tri-0SA, Tri-SA and Tri-2SA, however the low levels make these difficult to see in all of the figures. (Tri-3SA) and the appearance of the dark blue peak (Tri-0SA) after Sialidase S digestion for the first fraction; (C) the disappearance of the green peak (Tri-3SA) and the appearance of the purple peak (Tri-SA) after Sialidase S digestion for the second fraction; and (D) the disappearance of the green peak (Tri-3SA) and the appearance of the red peak (Tri-2SA) after Sialidase S digestion for the third fraction; and (E) no change of the green peak (Tri-3SA) after Sialidase S digestion for the fourth fraction. Figures B-E contain SRM traces for all four possible glycans resulting from this treatment, i.e., the Tri-0SA, Tri-SA, Tri-2SA and Tri-3SA, however the low levels make these difficult to see in all of the figures. 6 | P a g e 
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